Article metrics

Download PDFPDF

Targeting the TGFβ pathway with galunisertib, a TGFβRI small molecule inhibitor, promotes anti-tumor immunity leading to durable, complete responses, as monotherapy and in combination with checkpoint blockade

 

Online download statistics by month:

Online download statistics by month: December 2019 to July 2022

AbstractFullPdf
Dec 2019441
Jan 202015151
Feb 202024248
Mar 2020606012
Apr 20201021022
May 202010310318
Jun 2020383810
Jul 202040409
Aug 202032327
Sep 2020595914
Oct 202010410448
Nov 2020575729
Dec 2020999925
Jan 2021717121
Feb 2021484814
Mar 2021797931
Apr 2021858530
May 2021838337
Jun 2021808020
Jul 2021646418
Aug 2021717119
Sep 2021798031
Oct 2021707037
Nov 2021959539
Dec 2021646619
Jan 202282877
Feb 202212012220
Mar 2022879126
Apr 202211211429
May 202211111621
Jun 2022799225
Jul 2022818212
Total22982333640